BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24038018)

  • 1. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
    Sivaraman V; Yellon DM
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical translation of myocardial conditioning.
    Bøtker HE; Lassen TR; Jespersen NR
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1225-H1252. PubMed ID: 29498531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological pre- and post- conditioning agents: reperfusion-injury of the heart revisited.
    Andreadou I; Iliodromitis EK; Koufaki M; Kremastinos DT
    Mini Rev Med Chem; 2008 Aug; 8(9):952-9. PubMed ID: 18691153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of right coronary artery ischemic preconditioning on myocardial ischemia reperfusion injury 
in rabbit heart].
    Li J; Lin G; Huang R; Lu H; Yang Z; Luo W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 41(10):1047-1051. PubMed ID: 27807326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion.
    Breivik L; Helgeland E; Aarnes EK; Mrdalj J; Jonassen AK
    Basic Res Cardiol; 2011 Jan; 106(1):135-45. PubMed ID: 21103992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.
    Heusch G
    Compr Physiol; 2015 Jul; 5(3):1123-45. PubMed ID: 26140711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 5 different remifentanil strategies against myocardial ischemia-reperfusion injury.
    Chun KJ; Park YH; Kim JS; Jang Y; Kim JH; Kim J; Lee MY
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):926-30. PubMed ID: 21514843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Na
    Kingma JG
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):254-269. PubMed ID: 29562750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advance in the study of myocardial ischemic preconditioning and postconditioning and the clinical applications].
    Wu YJ; Fang LH; Du GH
    Yao Xue Xue Bao; 2013 Jul; 48(7):965-70. PubMed ID: 24133962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
    Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
    Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection from ischemia/reperfusion injury: basic and translational research.
    Minamino T
    Circ J; 2012; 76(5):1074-82. PubMed ID: 22504127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined effect of rosuvastatin and ischemic pre- or post-conditioning on myocardial ischemia-reperfusion injury in rat heart.
    Kelle I; Akkoç H; Uyar E; Erdinç M; Evliyaoğlu O; Sarıbaş S; Tunik S; Özoğul C
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2468-76. PubMed ID: 26214784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.